|
|
Volumn 15, Issue 1, 2006, Pages 14-18
|
|
What is the optimal reperfusion strategy for elderly patients with acute MI?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOLYTIC AGENT;
AGED;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HEART MUSCLE REPERFUSION;
HUMAN;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
UNITED STATES;
AGED;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
COMBINED MODALITY THERAPY;
FIBRINOLYTIC AGENTS;
HUMANS;
MYOCARDIAL INFARCTION;
MYOCARDIAL REPERFUSION;
RANDOMIZED CONTROLLED TRIALS;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 33748537044
PISSN: 10767460
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1076-7460.2006.05281.x Document Type: Review |
|
Times cited : (1)
|
|
References (27)
|
